Syneos Health

Syneos Health is a Biopharmaceutical Solutions company. It having approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. The headquarters is in USA.

Syneos Health was acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital for $43.00 per share in cash in a transaction valued at approximately $7.1 billion, including outstanding debt. Definitive agreement related to the acquisition was made in May-2023.